Login / Signup

A New Pipeline for the Normalization and Pooling of Metabolomics Data.

Vivian ViallonMathilde HisSabina RinaldiMarie BreeurAudrey GicquiauBertrand HemonKim OvervadAnne TjønnelandAgnetha Linn Rostgaard-HansenJoseph A RothwellLucie LecuyerGianluca SeveriRudolf KaaksTheron JohnsonMatthias Bernd SchulzeDomenico PalliClaudia AgnoliSalvatore PanicoRosario TuminoFulvio RicceriW M Monique VerschurenPeter EngelfrietCharlotte Onland-MoretRoel VermeulenTherese Haugdahl NøstIlona UrbarovaRaul Zamora RosMiguel Rodriguez-BarrancoPilar AmianoJosé María HouertaEva ArdanazOlle MelanderFilip OttossonLinda VidmanMatilda RentoftJulie A SchmidtRuth C TravisElisabete WeiderpassMattias JohanssonLaure DossusMazda JenabMarc J GunterJusto Lorenzo BermejoDominique SchererReza M SalekPekka Keski-RahkonenPietro Ferrari
Published in: Metabolites (2021)
Pooling metabolomics data across studies is often desirable to increase the statistical power of the analysis. However, this can raise methodological challenges as several preanalytical and analytical factors could introduce differences in measured concentrations and variability between datasets. Specifically, different studies may use variable sample types (e.g., serum versus plasma) collected, treated, and stored according to different protocols, and assayed in different laboratories using different instruments. To address these issues, a new pipeline was developed to normalize and pool metabolomics data through a set of sequential steps: (i) exclusions of the least informative observations and metabolites and removal of outliers; imputation of missing data; (ii) identification of the main sources of variability through principal component partial R-square (PC-PR2) analysis; (iii) application of linear mixed models to remove unwanted variability, including samples' originating study and batch, and preserve biological variations while accounting for potential differences in the residual variances across studies. This pipeline was applied to targeted metabolomics data acquired using Biocrates AbsoluteIDQ kits in eight case-control studies nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Comprehensive examination of metabolomics measurements indicated that the pipeline improved the comparability of data across the studies. Our pipeline can be adapted to normalize other molecular data, including biomarkers as well as proteomics data, and could be used for pooling molecular datasets, for example in international consortia, to limit biases introduced by inter-study variability. This versatility of the pipeline makes our work of potential interest to molecular epidemiologists.
Keyphrases